Hostname: page-component-74656f9884-8r8nv Total loading time: 0 Render date: 2026-11-09T22:12:07.405Z Has data issue: false hasContentIssue false

Percutaneous device closure of hemodynamically significant coronary fistula following endomyocardial biopsy in a pediatric heart transplant patient

Published online by Cambridge University Press:  02 August 2023

Stephen T. Dalby*
Affiliation:
Department of Pediatrics, University of Arkansas for Medical Sciences and Arkansas Children’s Research Institute, Little Rock, AR, USA Department of Pediatrics, University of California San Diego, Rady Children’s Hospital, San Diego, CA, USA
Michael J. Angtuaco
Affiliation:
Department of Pediatrics, University of Arkansas for Medical Sciences and Arkansas Children’s Research Institute, Little Rock, AR, USA
*
Corresponding author: S. Dalby; Email: SDalby@RCHSD.org
Rights & Permissions [Opens in a new window]

Abstract

Coronary artery fistula is a rare but well-documented complication of right ventricular endomyocardial biopsy, particularly in the adult population. Typically, these fistulae never reach clinical or hemodynamic significance, but some may cause coronary steal and ventricular dysfunction. We report a case of a significant coronary artery fistula requiring device closure in the cardiac catheterization laboratory with subsequent improvement of clinical symptoms and cardiac function.

Information

Type
Brief Report
Copyright
© The Author(s), 2023. Published by Cambridge University Press
Figure 0

Figure 1. Echocardiographic findings: a) colour compare image of the dilated left main coronary artery and left anterior descending, b) short axis image of dilated left ventricle and echo-bright anterolateral papillary muscle.

Figure 1

Figure 2. Angiographic findings: a,b) selective angiography of left coronary artery prior to device deployment demonstrates dilated left main and left anterior descending coronary arteries with a large fistulous connection (yellow arrows) to the right ventricle in AP and lateral projections; c,d) following device deployment (yellow arrows), there is no residual flow through the fistula and no obstruction to coronary flow.